Concepts (127)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| HIV-1 | 21 | 2025 | 710 | 2.140 |
Why?
|
| env Gene Products, Human Immunodeficiency Virus | 7 | 2018 | 60 | 1.120 |
Why?
|
| Viral Tropism | 7 | 2018 | 55 | 0.980 |
Why?
|
| Macrophages | 14 | 2018 | 1042 | 0.920 |
Why?
|
| CD4 Antigens | 11 | 2023 | 149 | 0.780 |
Why?
|
| HIV Envelope Protein gp120 | 9 | 2018 | 130 | 0.710 |
Why?
|
| HIV Infections | 11 | 2025 | 961 | 0.640 |
Why?
|
| Receptors, CCR5 | 7 | 2018 | 59 | 0.550 |
Why?
|
| Brain | 8 | 2018 | 1672 | 0.510 |
Why?
|
| AIDS Dementia Complex | 2 | 2006 | 11 | 0.460 |
Why?
|
| HIV Antibodies | 6 | 2018 | 146 | 0.450 |
Why?
|
| HIV-2 | 3 | 2013 | 23 | 0.450 |
Why?
|
| Virus Internalization | 3 | 2015 | 91 | 0.420 |
Why?
|
| Viral Load | 2 | 2013 | 230 | 0.410 |
Why?
|
| Preservation, Biological | 1 | 2013 | 5 | 0.380 |
Why?
|
| Virion | 4 | 2025 | 122 | 0.360 |
Why?
|
| HIV Fusion Inhibitors | 2 | 2011 | 10 | 0.350 |
Why?
|
| Lymph Nodes | 4 | 2011 | 237 | 0.350 |
Why?
|
| T-Lymphocytes | 1 | 2015 | 1013 | 0.320 |
Why?
|
| Tropism | 2 | 2006 | 15 | 0.300 |
Why?
|
| Genetic Variation | 2 | 2011 | 396 | 0.280 |
Why?
|
| nef Gene Products, Human Immunodeficiency Virus | 2 | 2025 | 26 | 0.270 |
Why?
|
| Semen | 1 | 2006 | 50 | 0.240 |
Why?
|
| ADAM10 Protein | 1 | 2025 | 11 | 0.220 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2025 | 76 | 0.220 |
Why?
|
| Gene Products, env | 1 | 2004 | 18 | 0.210 |
Why?
|
| Cell Line | 6 | 2023 | 2031 | 0.200 |
Why?
|
| Polymerase Chain Reaction | 1 | 2004 | 514 | 0.190 |
Why?
|
| CD4-Positive T-Lymphocytes | 4 | 2025 | 642 | 0.180 |
Why?
|
| Membrane Proteins | 2 | 2025 | 928 | 0.180 |
Why?
|
| Virus Cultivation | 2 | 2013 | 18 | 0.160 |
Why?
|
| Cells, Cultured | 4 | 2015 | 2195 | 0.150 |
Why?
|
| Global Burden of Disease | 1 | 2018 | 13 | 0.140 |
Why?
|
| Noncommunicable Diseases | 1 | 2018 | 19 | 0.140 |
Why?
|
| Virus Replication | 4 | 2025 | 323 | 0.140 |
Why?
|
| Particulate Matter | 1 | 2018 | 72 | 0.130 |
Why?
|
| Humans | 22 | 2025 | 65876 | 0.130 |
Why?
|
| Air Pollutants | 1 | 2018 | 100 | 0.130 |
Why?
|
| Nervous System Diseases | 1 | 2018 | 109 | 0.130 |
Why?
|
| Acquired Immunodeficiency Syndrome | 1 | 2017 | 129 | 0.120 |
Why?
|
| Antibodies, Neutralizing | 3 | 2018 | 220 | 0.120 |
Why?
|
| Environmental Exposure | 1 | 2018 | 228 | 0.120 |
Why?
|
| Neutralization Tests | 3 | 2018 | 126 | 0.120 |
Why?
|
| Receptors, HIV | 2 | 2012 | 16 | 0.110 |
Why?
|
| HIV Envelope Protein gp41 | 2 | 2025 | 27 | 0.110 |
Why?
|
| HeLa Cells | 4 | 2011 | 541 | 0.110 |
Why?
|
| Molecular Sequence Data | 5 | 2011 | 1980 | 0.100 |
Why?
|
| Simian Acquired Immunodeficiency Syndrome | 2 | 2005 | 62 | 0.100 |
Why?
|
| Simian Immunodeficiency Virus | 2 | 2005 | 84 | 0.100 |
Why?
|
| Virus Attachment | 1 | 2012 | 18 | 0.090 |
Why?
|
| Recombination, Genetic | 2 | 2011 | 256 | 0.090 |
Why?
|
| Amino Acid Substitution | 3 | 2009 | 238 | 0.090 |
Why?
|
| Amino Acid Sequence | 4 | 2010 | 1590 | 0.090 |
Why?
|
| Conserved Sequence | 1 | 2010 | 173 | 0.080 |
Why?
|
| Peptide Fragments | 2 | 2018 | 419 | 0.070 |
Why?
|
| Receptors, CCR3 | 1 | 2009 | 3 | 0.070 |
Why?
|
| Inhibitory Concentration 50 | 1 | 2008 | 52 | 0.070 |
Why?
|
| Antibodies, Monoclonal | 2 | 2012 | 875 | 0.070 |
Why?
|
| HEK293 Cells | 2 | 2025 | 617 | 0.070 |
Why?
|
| Arginine | 1 | 2008 | 136 | 0.060 |
Why?
|
| Polysaccharides | 1 | 2008 | 155 | 0.060 |
Why?
|
| Organ Specificity | 1 | 2006 | 201 | 0.060 |
Why?
|
| Microglia | 1 | 2009 | 254 | 0.060 |
Why?
|
| Species Specificity | 1 | 2006 | 344 | 0.060 |
Why?
|
| CCR5 Receptor Antagonists | 1 | 2005 | 17 | 0.060 |
Why?
|
| Phenotype | 2 | 2011 | 1236 | 0.060 |
Why?
|
| Genes, env | 2 | 2017 | 15 | 0.050 |
Why?
|
| Cell Fusion | 1 | 2004 | 39 | 0.050 |
Why?
|
| Phylogeny | 2 | 2018 | 400 | 0.050 |
Why?
|
| Membrane Microdomains | 1 | 2004 | 51 | 0.050 |
Why?
|
| Protein Binding | 3 | 2018 | 1638 | 0.050 |
Why?
|
| Infant | 1 | 2008 | 1721 | 0.050 |
Why?
|
| HIV | 1 | 2003 | 67 | 0.050 |
Why?
|
| Infant, Newborn | 1 | 2006 | 1441 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2023 | 332 | 0.040 |
Why?
|
| Membrane Glycoproteins | 1 | 2023 | 667 | 0.040 |
Why?
|
| Adult | 2 | 2008 | 17595 | 0.040 |
Why?
|
| Sequence Alignment | 2 | 2010 | 302 | 0.040 |
Why?
|
| Receptors, Virus | 1 | 2018 | 73 | 0.030 |
Why?
|
| Bayes Theorem | 1 | 2018 | 127 | 0.030 |
Why?
|
| Air Pollution | 1 | 2018 | 42 | 0.030 |
Why?
|
| Global Health | 1 | 2018 | 181 | 0.030 |
Why?
|
| Protein Multimerization | 1 | 2018 | 181 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2017 | 99 | 0.030 |
Why?
|
| Animals | 4 | 2011 | 21497 | 0.030 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2018 | 186 | 0.030 |
Why?
|
| Proportional Hazards Models | 1 | 2018 | 746 | 0.030 |
Why?
|
| Flow Cytometry | 1 | 2018 | 664 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2018 | 472 | 0.030 |
Why?
|
| Gene Expression | 1 | 2018 | 856 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2018 | 2653 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 2116 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2011 | 52 | 0.020 |
Why?
|
| Time Factors | 1 | 2018 | 3780 | 0.020 |
Why?
|
| Immunization | 1 | 2011 | 135 | 0.020 |
Why?
|
| Recombinant Proteins | 1 | 2012 | 710 | 0.020 |
Why?
|
| Rabbits | 1 | 2011 | 342 | 0.020 |
Why?
|
| Sequence Analysis, DNA | 1 | 2011 | 417 | 0.020 |
Why?
|
| Male | 2 | 2011 | 31437 | 0.020 |
Why?
|
| Mutagenesis, Site-Directed | 1 | 2009 | 252 | 0.020 |
Why?
|
| Antibodies | 1 | 2009 | 188 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2009 | 190 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2008 | 137 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 1 | 2008 | 365 | 0.020 |
Why?
|
| Protein Structure, Secondary | 1 | 2008 | 261 | 0.020 |
Why?
|
| Models, Biological | 1 | 2012 | 1193 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2008 | 449 | 0.020 |
Why?
|
| Chemokine CCL5 | 1 | 2005 | 32 | 0.010 |
Why?
|
| Binding Sites | 1 | 2008 | 922 | 0.010 |
Why?
|
| Kidney | 1 | 2008 | 460 | 0.010 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2005 | 33 | 0.010 |
Why?
|
| RNA Interference | 1 | 2009 | 647 | 0.010 |
Why?
|
| Amides | 1 | 2005 | 61 | 0.010 |
Why?
|
| Down-Regulation | 1 | 2005 | 326 | 0.010 |
Why?
|
| Female | 1 | 2006 | 34460 | 0.010 |
Why?
|
| Cysteine | 1 | 2004 | 108 | 0.010 |
Why?
|
| Monocytes | 1 | 2005 | 362 | 0.010 |
Why?
|
| Structure-Activity Relationship | 1 | 2004 | 357 | 0.010 |
Why?
|
| Receptors, Cell Surface | 1 | 2005 | 432 | 0.010 |
Why?
|
| Receptors, CXCR4 | 1 | 2003 | 43 | 0.010 |
Why?
|
| Cytoplasm | 1 | 2004 | 283 | 0.010 |
Why?
|
| RNA, Small Interfering | 1 | 2009 | 993 | 0.010 |
Why?
|
| Macaca mulatta | 1 | 2003 | 263 | 0.010 |
Why?
|
| T-Lymphocyte Subsets | 1 | 2003 | 241 | 0.010 |
Why?
|
| Protein Conformation | 1 | 2003 | 793 | 0.010 |
Why?
|
| Mutation | 1 | 2004 | 2676 | 0.010 |
Why?
|
| Mice | 1 | 2009 | 11189 | 0.010 |
Why?
|